Journal · Psychopharmacology · Updated 15 November 2026
Psychopharmacology
Read Psychopharmacology research on DeepDyve. No university library needed.
Psychopharmacology, published by Springer Nature, covers research on how drugs affect the brain, behavior and mental states, and has appeared under its current title since 1976. Its papers include laboratory studies in animals and human studies of psychedelics, MDMA and other psychoactive drugs, from receptor pharmacology to user surveys. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.
Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.
Personal plans aren’t for business use. Reading for work? See Enterprise.
Psychopharmacology at a glance
- Full title
- Psychopharmacology
- Abbreviation (NLM)
- Psychopharmacology (Berl)
- Publisher
- Springer Nature
- Print ISSN
- 0033-3158
- Online ISSN (eISSN)
- 1432-2072
- Current title since
- 1976
- Subjects
- Psychopharmacology
- Access model
- Hybrid: subscription, with an open access option
- On DeepDyve
- Research articles; availability varies by article
Ways to access Psychopharmacology
57% of the articles Psychopharmacology published from January 1 to November 14, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.
- Open access articles. 57% of Psychopharmacology articles published from January 1 to November 14, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
- The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
- Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
- NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
- A library. Your university, hospital or public library may subscribe to Psychopharmacology. Check its journal list and whether it offers remote access.
- DeepDyve. Read Psychopharmacology articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.
Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.
Recent Psychopharmacology research worth reading
Published September to October 2026. Summaries describe what the authors report.
-
Moving beyond 5-HT2A: language models map neurotransmitter receptors to experiential semantics
Combining a word-embedding model trained on 4,496 firsthand experience reports with receptor affinities for 21 psychedelic drugs, the authors report that 5-HT2A was associated with classic facets of psychedelic experience, alongside new associations such as 5-HT1A and 5-HT1B with “Cognitive Disruption.”
Suresh et al. · Psychopharmacology, published online September 29, 2026 · DOI 10.1007/s00213-026-07170-0
-
What goes up must comedown: prevalence rates, characteristics, and coping strategies concerning MDMA aftereffects
In an online survey of 497 people who had used MDMA, the authors report that 74.5% had experienced a period of negative aftereffects at least once, starting about 24 hours after ingestion and lasting 40 hours on average, with fatigue (88.1%) the most common symptom.
Psychopharmacology, October 2026 · DOI 10.1007/s00213-026-07187-5
-
Investigation of the pharmacological and circuit basis for psychedelic drug effects on interval timing in mice
Testing mice on an interval timing task, the authors report that psilocin altered timing accuracy and precision, an effect blocked by a 5-HT2A antagonist but not by a 5-HT1A antagonist, and that infusing the psychedelic DOI into the medial prefrontal cortex mimicked its systemic effects.
Klein et al. · Psychopharmacology, published online October 19, 2026 · DOI 10.1007/s00213-026-07181-x
Questions about Psychopharmacology
How can I read Psychopharmacology articles without a subscription?
57% of Psychopharmacology articles published from January 1 to November 14, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read Psychopharmacology articles online for $59 a month or $499 a year after a free first month.
What is the abbreviation for Psychopharmacology?
Psychopharmacology’s NLM (PubMed) abbreviation is Psychopharmacology (Berl).
What is the ISSN of Psychopharmacology?
The print ISSN is 0033-3158 and the online ISSN is 1432-2072.
Is Psychopharmacology open access?
Psychopharmacology is a hybrid journal: most articles are published under the subscription model, and authors can choose to publish open access. From January 1 to November 14, 2026, 122 of 213 Psychopharmacology articles (57%) carry a Creative Commons license, per Crossref.
Psychopharmacology articles on DeepDyve are licensed from Springer Nature. Journal facts as of 15 November 2026.
Start reading Psychopharmacology today
One month free, then less than $2 a day. Psychopharmacology, plus millions of articles from thousands of journals.
